Novo Nordisk has announced the launch of a daily oral pill version of its weight-loss injection, Wegovy, just two weeks after the new formulation was approved by regulators
When prescribed and monitored by qualified medical providers, GLP-1 medications are generally considered safe for many patients
While they do slightly increase heart rate, they still reduce overall cardiovascular risk
doi: 10.3389/fendo.2023.1217669 43 MpekrisFPanagiMMichaelCVoutouriCTsuchiyaMWagatsumaC
This can reduce methylation, contributing to a wide range of MTHFR gene symptoms
Precision obesity medicine matching patients to specific GLP-1 mechanisms based on genetic predictors, gut microbiome profiles, and metabolic phenotyping represents an emerging differentiation opportunity